Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China
The Pharma Data
DECEMBER 20, 2020
21, 2020 (GLOBE NEWSWIRE) — Shanghai Haini Pharmaceutical Co., They are one of the top pharmaceutical firms in China and are considered a market leader in the antibiotics space. There is an urgent need in China, and indeed, globally, to bring new antibiotics to the market that can address critical resistance issues.
Let's personalize your content